NIH-funded research NIH-funded research

New technology to study how drugs interact with proteins

Official title: Technology for evaluating drug-binding responses to small-molecule perturbation

Funded at University of Washington · NIH-10931378 · Data updated 2026-11-12

This study is exploring new technology to see how well different drugs and molecules connect with proteins in our bodies, which could help improve how effective these treatments are for various health conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 25, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$388,750
NIH project number5R35GM150919-02
Project IDNIH-10931378 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions that could benefit from improved drug therapies targeting specific protein interactions.

Less likely to help

Patients who are not currently seeking new treatments or those with conditions unrelated to protein-ligand interactions may not benefit from this research.

What this research studies

This research focuses on developing advanced technology to evaluate how drugs and other molecules bind to proteins, which are crucial for many biological functions. By using high-throughput methods, the project aims to analyze protein-ligand interactions across the entire set of human proteins in a single experiment. The approach involves measuring changes in protein stability when they bind to different ligands, allowing for a comprehensive understanding of these interactions. This could lead to better insights into drug efficacy and the biological processes they influence.

Why it matters

Potential benefit: If successful, this research could enhance the development of more effective drugs by providing deeper insights into how they interact with proteins in the body.

How similar studies have gone: Other research has shown promise in using high-throughput methods for studying protein interactions, indicating that this approach could lead to significant advancements in the field.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Schweppe, Devin Karl — University of Washington
  • Study coordinator: Schweppe, Devin Karl

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.